Obesity is a major driver of US health care costs, totaling almost $173 billion annually, according to the CDC in 2024
In addition to the negative regulation of fat intake, enterostatin increases energy expenditure through both central and peripheral pathways
Future studies should consider the different forms of cell death, whether they act simultaneously or successively through interactions, and whether any one of these cell death pathways plays a predominant role
They are often used to combat fatigue and stress
For many patients, that translates to stronger appetite suppression, improved metabolic effects, and greater total weight loss
Healthcare professionals can prescribe compounded tirzepatide to adults with obesity and overweight with at least one weight-related condition such as heart disease, high blood pressure, type 2 diabetes, and high levels of cholesterol